ondansetron has been researched along with Atypical Cluster Headache in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The increase obtained in migraine after ergotamine is more evident than that obtained in cases of cluster headache." | 1.29 | Upregulated expression of peripheral serotonergic receptors in migraine and cluster headache by sumatriptan. ( Giacovazzo, M; Martelletti, P; Rinaldi, C; Stirparo, G, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martelletti, P | 1 |
| Stirparo, G | 1 |
| Rinaldi, C | 1 |
| Giacovazzo, M | 1 |
1 other study available for ondansetron and Atypical Cluster Headache
| Article | Year |
|---|---|
Upregulated expression of peripheral serotonergic receptors in migraine and cluster headache by sumatriptan.
Topics: Adult; Analysis of Variance; Binding, Competitive; Cluster Headache; Ergotamine; Female; Flow Cytome | 1994 |